Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
2000 participants
INTERVENTIONAL
2024-03-28
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does the BE FAST acronym increase understanding among participants that calling 911 is the right first step they should take if a stroke is suspected?
* Does the BE FAST acronym perform as well as or better than the F.A.S.T. acronym in helping participants remember stroke warning signs on a letter-aided open-ended basis? Researchers will compare the BE FAST acronym to the F.A.S.T. acronym to see if the BE FAST acronym works at least as well as the F.A.S.T. acronym in teaching participants about the warning signs of a stroke and the importance of calling 911 if they suspect a stroke.
Participants will:
* Take a survey about their knowledge of stroke and its symptoms
* Watch a short video about one of the acronyms and then answer more questions about what they learned
* Take another survey after 30 days about the acronym they learned about
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
NCT03861494
Mild and Rapidly Improving Stroke Study
NCT02072681
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
NCT01976936
Biomarkers of Acute Stroke in Clinic
NCT03897478
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
NCT01092819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BE FAST Group
The experimental BE FAST acronym education messaging, including 5 stroke warning signs and a call-to-action to call 911, will be shown to the participants using a brief video.
BE FAST Educational video
A 1-minute educational video format using BE FAST. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
F.A.S.T. Group
The comparator F.A.S.T. acronym education messaging, including 3 stroke warning signs and a call-to-action to call 911, will be shown to the participants using a brief video.
F.A.S.T. Educational Video
A 1-minute educational video format using F.A.S.T. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BE FAST Educational video
A 1-minute educational video format using BE FAST. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
F.A.S.T. Educational Video
A 1-minute educational video format using F.A.S.T. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have access to a computer, tablet or mobile device with internet services;
* Proficient in reading and writing the English language; and
* Reside outside a medical facility.
Exclusion Criteria
* Do not have access to a computer, tablet or mobile device with internet;
* Not proficient in reading and writing in English language; or
* Reside in a medical facility.
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Opeolu Adeoye, MD
Role: STUDY_CHAIR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American Heart Association
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00077822
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.